Photodynamic therapy for Barrett’s esophagus: does light still have a role?

References

• 1 Siersema P D. Photodynamic therapy for Barrett"s esophagus: not yet ready for the premier league of endoscopic interventions.  Gastrointestinal Endoscopy. 2005;  62 503-507
• 2 Wilson B C, Patterson M S, Wilson B C, Patterson M S. The physics, biophysics and technology of photodynamic therapy.  Phys Med Biol. 2008;  53 61-R109
• 3 Birkmeyer J D, Stukel T A, Siewers A E. et al . Surgeon volume and operative mortality in the United States.  N Engl J Med. 2003;  349 2117-2127
• 4 Lightdale C J, Heier S K, Marcon N E. et al . Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial.  Gastrointest Endosc. 1995;  42 507-512
• 5 Dougherty T. Photodynamic therapy for early esophageal cancer [abstract]. International Photodynamic Therapy Association Meeting 1990. 
• 6 Laukka M A, Wang K K. Initial results using low-dose photodynamic therapy in the treatment of Barrett’s esophagus.  Gastrointest Endosc. 1995;  42 59-63
• 7 Overholt B F, Panjehpour M. Barrett’s esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer.  Gastrointest Endosc. 1995;  42 64-70
• 8 Overholt B F, Lightdale C J, Wang K K. et al . Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial. [Erratum appears in Gastrointest Endosc 2006; 63 : 359].  Gastrointest Endosc. 2005;  62 488-498
• 9 Overholt B F, Wang K K, Burdick J S. et al . Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia.  Gastrointest Endosc. 2007;  66 460-468
• 10 Pech O, Gossner L, May A. et al . Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett’s cancer and high-grade intraepithelial neoplasia.  Gastrointest Endosc. 2005;  62 24-30
• 11 Hage M, Siersema P D, van Dekken H. et al . 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial.  Gut. 2004;  53 785-790
• 12 Peters F, Kara M, Rosmolen W. et al . Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in Barrett esophagus after endoscopic resection.  Endoscopy. 2005;  37 418-424
• 13 Mackenzie G D, Jamieson N F, Novelli M R. et al . How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett’s esophagus.  Lasers in Med Sci. 2008;  23 203-210
• 14 Hur C, Nishioka N S, Gazelle G S. Cost-effectiveness of photodynamic therapy for treatment of Barrett’s esophagus with high grade dysplasia.  Dig Dis Sci. 2003;  48 1273-1283
• 15 Shaheen N J, Inadomi J M, Overholt B F, Sharma P. What is the best management strategy for high grade dysplasia in Barrett’s oesophagus? A cost effectiveness analysis.  Gut. 2004;  53 1736-1744
• 16 Comay D, Blackhouse G, Goeree R. et al . Photodynamic therapy for Barrett’s esophagus with high-grade dysplasia: a cost-effectiveness analysis.  Can J Gastroenterol. 2007;  21 217-222
• 17 Comay D, Blackhouse G, Goeree R. et al . Photodynamic therapy for Barrett’s esophagus with high-grade dysplasia: a cost-effectiveness analysis.  Can J Gastroenterol. 2007;  21 217-222
• 18 Prasad G A, Wang K K, Buttar N S. et al . Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett’s esophagus.  Gastrointest Endosc. 2007;  65 60-66
• 19 Prasad G A, Wang K K, Buttar N S. et al . Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus.  Gastroenterology. 2007;  132 1226-1233
• 20 Sharma V K, Wang K K, Overholt B F. et al . Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patients.  Gastrointest Endosc. 2007;  65 185-195
• 21 Mörk H, Barth T, Kreipe H H. et al . Reconstitution of squamous epithelium in Barrett’s oesophagus with endoscopic argon plasma coagulation: a prospective study.  Scand J Gastroenterol. 1998;  33 1130-1134
• 22 Van Laethem J L, Cremer M, Peny M O. et al . Eradication of Barrett’s mucosa with argon plasma coagulation and acid suppression: immediate and mid term results.  Gut. 1998;  43 747-751
• 23 Cheung R, Solonenko M, Busch T M. et al . Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model.  J Biomed Optics. 2003;  8 248-252
• 24 Solonenko M. In vivo reflectance measurement of optical properties, blood oxygenation and motexafin lutetium uptake in canine large bowels, kidneys and prostates.  Phys Med Biol. 2002;  47 857-873
• 25 Sessler J L, Miller R A. Texaphyrins: new drugs with diverse clinical applications in radiation and photodynamic therapy.  Biochem Pharmacol. 2000;  59 733-739
• 26 Vargas A, Eid M, Fanchaouy M. et al . In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties, administration parameters and biological issues involved in PDT outcome.  Eur J Pharm Biopharm. 2008;  69 43-53
• 27 Saw C L, Heng P W, Olivo M. et al . Potentiation of the photodynamic action of hypericin.  J Environ Pathol Toxicol Oncol. 2008;  27 23-33
• 28 Minnes R, Weitman H, You Y. et al . Dithiaporphyrin derivatives as photosensitizers in membranes and cells.  J Phys Chem B. 2008;  112 3268-3276
• 29 Cole C D, Liu J K, Sheng X. et al . Hypericin-mediated photodynamic therapy of pituitary tumors: preclinical study in a GH4C1 rat tumor model.  J Neurooncol. 2008;  87 255-261
• 30 Trachtenberg J, Bogaards A, Weersink R A. et al . Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response.  J Urol. 2007;  178 1974-1979; discussion 1979
• 31 Taquet J P, Frochot C, Manneville V. et al . Phthalocyanines covalently bound to biomolecules for a targeted photodynamic therapy.  Curr Med Chem. 2007;  14 1673-1687
• 32 Prasad G A, Wang K K, Halling K C. et al . Utility of biomarkers in prediction of response to ablative therapy in Barrett’s esophagus.  Gastroenterology. 2008;  135 370-379